English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 28 September 2012, 21:15 HKT/SGT
Share:
    

Source: Omnicare
Don Wetherhold Joins Omnicare as SVP, Long-Term Care Group

CINCINNATI, OH, Sept 28, 2012 - (ACN Newswire) - Omnicare, Inc. (NYSE: OCR) today announced Don Wetherhold has been appointed Senior Vice President, Long-Term Care Group, effective October 1, 2012.

Mr. Wetherhold will oversee and lead customer retention, national accounts and automation in Omnicare's Long-Term Care business. He will report directly to Nitin Sahney, Omnicare's President and Chief Operating Officer.

"We are delighted to welcome Don to Omnicare," said Sahney. "With his extensive background as a results-oriented healthcare leader, we are confident his operational expertise will help us to further leverage our Long-Term Care platform. He will be an integral part of our continuing efforts to enhance the customer experience."

Mr. Wetherhold brings to Omnicare extensive experience within pharmaceutical services. He was formerly Corporate Commercialization Officer at Aprecia Pharmaceuticals, a specialty pharmaceutical company based on a breakthrough technology platform. Prior to that, he served in roles leading and supporting business development initiatives at Prasco, which is the majority shareholder in Aprecia. He has also served in senior roles at Cardinal Health, including as President of Sales and Marketing Services and President of RxPedite, where he conceptualized and sold the business model of providing commercialization and launch solutions to emerging pharmaceutical and biotechnology companies. In addition, he previously was Vice President of Business Development at Snyder Healthcare Sales and was Regional Business Unit Director at Solvay Pharmaceutical in Belgium.

Mr. Wetherhold received a Bachelor of Science degree from West Chester University of Pennsylvania and a Master of Education in Educational Leadership degree from Florida Atlantic University.

About Omnicare

Omnicare, Inc., a Fortune 400 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across North America. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides key commercialization services for the bio-pharmaceutical industry and end-of-life disease management through its Specialty Care Group. For more information, visit www.omnicare.com .

Contact:

Media:
Ed Loyd
+1-513-719-0808
Ed.loyd@omnicare.com

Investors:
Patrick C. Lee
+1-513-719-1507
patrick.lee@omnicare.com


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Omnicare via Thomson Reuters ONE

Topic: Press release summary
Source: Omnicare


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Omnicare Related News
Sept 16, 2015 07:55 HKT/SGT
Omnicare Trust PIERS to Accrue Contingent Interest
Aug 19, 2015 07:35 HKT/SGT
Omnicare Announces Conversion Rate Adjustments for Convertible Notes
July 24, 2015 20:40 HKT/SGT
Omnicare Reports Second-Quarter 2015 Financial Results
June 20, 2015 06:05 HKT/SGT
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
May 22, 2015 06:30 HKT/SGT
Omnicare Declares Quarterly Cash Dividend
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575